US2007060746A1PendingUtilityA1

Processes for preparation of 9,11 epoxy steroids and intermediates useful therein

Assignee: G D SEARLE LLC FORMERLY NAMEDPriority: Dec 11, 1995Filed: Jul 21, 2006Published: Mar 15, 2007
Est. expiryDec 11, 2015(expired)· nominal 20-yr term from priority
C07J 21/003C07J 53/002C07J 71/00C07J 53/00C07J 31/006C12P 33/10C12P 33/005C07J 21/00C07J 71/0015C12Q 1/02
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Multiple novel reaction schemes, novel process steps and novel intermediates are provided for the synthesis of epoxymexrenone and other compounds of Formula I wherein: -A-A- represents the group —CHR 4 —CHR 5 — or —CR 4 ═CR 5 — —R 3 , R 4 and R 5 are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, R 1 represents an alpha-oriented lower alkoxycarbonyl or hydroxyalkyl radical, —B—B— represents the group —CHR 6 —CHR 7 — or an alpha- or beta-oriented group: where R 6 and R 7 are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, aryloxy, and R 8 and R 9 are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, aryloxy, or R 8 and R 9 together comprise a carbocyclic or heterocyclic ring structure, or R 8 or R 9 together with R 6 or R 7 comprise a carbocyclic or heterocyclic ring structure fused to the pentacyclic D ring.

Claims

exact text as granted — not AI-modified
1 - 65 . (canceled)  
   
   
       66 . A compound of Formula VIII  
     
       
         
         
             
             
         
       
     
     wherein 
 -A-A- represents the group —CHR 4 —CHR 5 — or —CR 4 ═CR 5 — 
 R 3 , R 4  and R 5  are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy,  
 —B—B— represents the group —CHR 6 —CHR 7 — or an alpha- or beta-oriented group:  
                     
 where R 6  and R 7  are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, and aryloxy, and  
 R 8  and R 9  are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, and aryloxy, or R 8  and R 9  together comprise a carbocyclic or heterocyclic ring structure, or R 8  and R 9  together with R 6  or R 7  comprise a carbocyclic or heterocyclic ring structure fused to the pentacyclic D ring.  
 
   
   
       67 . A compound of Formula VIII as set forth in  claim 66  wherein said compound corresponds to Formula VIIIA:  
     
       
         
         
             
             
         
       
     
     wherein: 
 -A-A- represents the group —CH 2 —CH 2 — or —CH═CH—,  
 —B—B— represents the group —CH 2 —CH 2 — or an alpha- or beta-oriented group:  
                     
 X represents two hydrogen atoms or oxo,  
 Y 1  and Y 2  together represent the oxygen bridge —O—, or  
 Y 1  represents hydroxy, and  
 Y 2  represents hydroxy, lower alkoxy or, if X represents H 2 , also lower alkanoyloxy, and salts of compounds in which X represents oxo and Y 2  represents hydroxy.  
 
   
   
       68 . A compound of Formula VIII as set forth in  claim 66  wherein said compound is  
     
       
         
         
             
             
         
       
     
   
   
       69 . A compound according to  claim 66 , wherein said compound of Formula VIII is 11α,17α-Dihydroxy-3-oxopregna-4,6-diene-21-carboxylic Acid, γ-Lactone.  
   
   
       70 . A compound of Formula XIV:  
     
       
         
         
             
             
         
       
       wherein: 
 -A-A- represents the group —CHR 4 —CHR 5 — or —CR 4 ═CR 5 —,  
 R 3 , R 4  and R 5  are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy, and  
 —B—B— represents the group —CHR 6 —CHR 7 — or an alpha- or beta-oriented group:  
                     
 
       where R 6  and R 7  are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, and aryloxy.  
     
   
   
       71 . A compound of  claim 70  wherein: 
 R 3  is hydrogen,    -A-A- represents the group —CH 2 —CH 2 —, and    —B—B— represents the group —CH 2 —CH 2 —.    
   
   
       72 . A compound of  claim 70  having the structural formula:  
     
       
         
         
             
             
         
       
     
   
   
       73 . A compound corresponding to Formula 101:  
     
       
         
         
             
             
         
       
       wherein: 
 -A-A-  
 
       represents the group — 
       CHR 4 —CHR 5 — or —CR 4 ═CR 5 —, 
 R 3 , R 4  and R 5  are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy,  
 R 11  is C 1 -C 4  alkyl, and  
 —B—B— represents the group —CHR 6 —CHR 7 — or an alpha- or beta-oriented group:  
                     
 
       where R 6  and R 7  are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, and aryloxy.  
     
   
   
       74 . A compound of  claim 73  wherein: 
 R 3  is selected from the group consisting of hydrogen, lower alkyl and lower alkoxy,    -A-A- represents the group —CH 2 —CH 2 —, and    —B—B— represents the group —CH 2 —CH 2 —.    
   
   
       75 . A compound of  claim 73  wherein R 3  is hydrogen.  
   
   
       76 . A compound of  claim 74  wherein R 11  is methyl.  
   
   
       77 . A compound of  claim 74  wherein R 11  is ethyl.

Join the waitlist — get patent alerts

Track US2007060746A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.